These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17579266)

  • 1. Trafficking of QD-conjugated MPO-ANCA in murine systemic vasculitis and glomerulonephritis model mice.
    Hoshino A; Nagao T; Ito-Ihara T; Ishida-Okawara A; Uno K; Muso E; Nagi-Miura N; Ohno N; Tokunaka K; Naoe S; Hashimoto H; Yasuhara M; Yamamoto K; Suzuki K
    Microbiol Immunol; 2007; 51(5):551-66. PubMed ID: 17579266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
    Schreiber A; Xiao H; Falk RJ; Jennette JC
    J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MPO-ANCA induces IL-17 production by activated neutrophils in vitro via classical complement pathway-dependent manner.
    Hoshino A; Nagao T; Nagi-Miura N; Ohno N; Yasuhara M; Yamamoto K; Nakayama T; Suzuki K
    J Autoimmun; 2008 Aug; 31(1):79-89. PubMed ID: 18501296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic dissection of vasculitis, myeloperoxidase-specific antineutrophil cytoplasmic autoantibody production, and related traits in spontaneous crescentic glomerulonephritis-forming/Kinjoh mice.
    Hamano Y; Tsukamoto K; Abe M; Sun GD; Zhang D; Fujii H; Matsuoka S; Tanaka M; Ishida-Okawara A; Tachikawa H; Nishimura H; Tokunaka K; Hirose S; Suzuki K
    J Immunol; 2006 Mar; 176(6):3662-73. PubMed ID: 16517735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
    Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
    Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of myeloperoxidase and myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCAs) in the pathogenesis of human MPO-ANCA-associated glomerulonephritis.
    Arimura Y; Kawashima S; Yoshihara K; Komagata Y; Kaname S; Yamada A
    Clin Exp Nephrol; 2013 Oct; 17(5):634-637. PubMed ID: 23504409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha.
    Huugen D; Xiao H; van Esch A; Falk RJ; Peutz-Kootstra CJ; Buurman WA; Tervaert JW; Jennette JC; Heeringa P
    Am J Pathol; 2005 Jul; 167(1):47-58. PubMed ID: 15972951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
    Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
    Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil functions of patients with vasculitis related to myeloperoxidase-specific anti-neutrophil antibody.
    Suzuki K
    Int J Hematol; 2001 Aug; 74(2):134-43. PubMed ID: 11594512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of myeloperoxidase in vasculitis development.
    Suzuki K; Okazaki T
    Jpn J Infect Dis; 2004 Oct; 57(5):S2-3. PubMed ID: 15507759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mouse model for MPO-ANCA-associated glomerulonephritis.
    Yumura W; Itabashi M; Ishida-Okawara A; Tomizawa K; Yamashita J; Kaneshiro Y; Nihei H; Suzuki K
    Microbiol Immunol; 2006; 50(2):149-57. PubMed ID: 16490933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloperoxidase (MPO)-specific CD4+ T cells contribute to MPO-anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis.
    Gan PY; Holdsworth SR; Kitching AR; Ooi JD
    Cell Immunol; 2013 Mar; 282(1):21-7. PubMed ID: 23665205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-neutrophil cytoplasmic antibody MPO-ANCA related with disease activity of vasculitis].
    Suzuki K
    Nihon Rinsho Meneki Gakkai Kaishi; 2006 Apr; 29(2):94-101. PubMed ID: 16651707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis.
    Ooi JD; Chang J; Hickey MJ; Borza DB; Fugger L; Holdsworth SR; Kitching AR
    Proc Natl Acad Sci U S A; 2012 Sep; 109(39):E2615-24. PubMed ID: 22955884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
    Ruth AJ; Kitching AR; Kwan RY; Odobasic D; Ooi JD; Timoshanko JR; Hickey MJ; Holdsworth SR
    J Am Soc Nephrol; 2006 Jul; 17(7):1940-9. PubMed ID: 16769746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of myeloperoxidase to coronary artery vasculitis associated with MPO-ANCA production.
    Ishida-Okawara A; Oharaseki T; Takahashi K; Hashimoto Y; Aratani Y; Koyama H; Maeda N; Naoe S; Suzuki K
    Inflammation; 2001 Dec; 25(6):381-7. PubMed ID: 11831441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic role and clinical relevance of antineutrophil cytoplasmic antibodies in vasculitides.
    Shovman O; Gilburd B; Zandman-Goddard G; Sherer Y; Shoenfeld Y
    Curr Rheumatol Rep; 2006 Aug; 8(4):292-8. PubMed ID: 16839508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C5a receptor 1 promotes autoimmunity, neutrophil dysfunction and injury in experimental anti-myeloperoxidase glomerulonephritis.
    Dick J; Gan PY; Ford SL; Odobasic D; Alikhan MA; Loosen SH; Hall P; Westhorpe CL; Li A; Ooi JD; Woodruff TM; Mackay CR; Kitching AR; Hickey MJ; Holdsworth SR
    Kidney Int; 2018 Mar; 93(3):615-625. PubMed ID: 29241626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1β secretion in response to anti-MPO antibodies.
    O'Brien EC; Abdulahad WH; Rutgers A; Huitema MG; O'Reilly VP; Coughlan AM; Harrington M; Heeringa P; Little MA; Hickey FB
    Sci Rep; 2015 Jul; 5():11888. PubMed ID: 26149790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of MPO-ANCA-mediated oxidative imbalance on renal vasculitis.
    Hilhorst M; Maria AT; Kavian N; Batteux F; Borderie D; Le Quellec A; van Paassen P; Guilpain P
    Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1769-F1776. PubMed ID: 30207165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.